Keyphrases
Acute Respiratory Viral Infections
25%
Airway
25%
Airway Inflammation
50%
Airway Obstruction
25%
Antioxidant Capacity
25%
Antioxidant Enzymes
25%
Antioxidant Gene Expression
25%
Antioxidant Response
25%
Antioxidant System
100%
Chemokine Secretion
25%
Clinical Disease
25%
Cytokine Secretion
25%
Effect Types
25%
Human Lung
25%
Infected Mice
25%
Infection Model
25%
Inflammation Injury
25%
Interferon Production
25%
Interferon Receptor
50%
Lung
25%
Lung Disease
25%
Lung Inflammation
100%
Mouse Lung
25%
Mouse Model
25%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
100%
Oxidative Damage
25%
Pathogenic Response
25%
Promyelocytic Leukemia
25%
Protective Effect
25%
Protein Expression
25%
Respiratory Syncytial Virus
100%
Respiratory Syncytial Virus Infection
50%
Therapeutic Strategies
25%
Transcription Factor
25%
Two-level
25%
Type I IFN
25%
Type I Interferon
25%
Type I Interferon Signaling
100%
Viral
25%
Virus
50%
Weight Loss
25%
Medicine and Dentistry
Acute Promyelocytic Leukemia
25%
Airway Obstruction
25%
Antioxidant
100%
Antioxidant Capacity
25%
Antioxidant Enzyme
50%
Body Weight Loss
25%
Chemokine
25%
Cytokine
25%
Disease
25%
Epileptic Absence
25%
Human Respiratory Syncytial Virus
100%
Infection
25%
Injury
25%
Interferon Production
25%
Interferon Receptor
50%
Interferon Type I
100%
Mediator
25%
Pneumonia
100%
Protein Expression
50%
Respiratory Syncytial Virus Infection
50%
Respiratory Tract Inflammation
50%
Secretion (Process)
25%
Silo-Filler's Disease
25%
Transcription Factor Nrf2
100%
Viral Respiratory Tract Infection
25%
Immunology and Microbiology
Body Weight Loss
25%
Chemokine
25%
Cytokine
25%
Human Respiratory Syncytial Virus
100%
interferon
100%
Interferon Production
25%
Mediator
25%
Mouse
50%
Mouse Model
25%
Protein Expression
50%
Pulmonary Inflammation
100%
Respiratory Syncytial Virus Infection
50%
Secretion (Process)
25%
Transcription Factor Nrf2
100%
Viral Disease
25%